$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

BioMarin Pharmaceutical Inc. Settlement
(NASDAQ: BMRN)
Settlement

Claim Deadline: October 30, 2023

Settlement Fund: $39,000,000

Settlement Class

All persons or entities that  purchased or otherwise acquired the common stock of BioMarin Pharmaceutical Inc. (“BioMarin” or the “Company”) from March 3, 2020 through August 18, 2020, inclusive.

Important Documents

Settlement Notice

Settlement Status

Disbursed

Class Period

March 03, 2020 - November 16, 2020

Settlement Hearing Date

November 08, 2023

Opt-Out Deadline

October 18, 2023

Settlement Website

https://www.biomarinsecuritieslitigation.com/

Claims Admin

A.B. Data, Ltd.
BioMarin Securities Litigation
c/o A.B. Data, Ltd.
P.O. Box 170400
Milwaukee, WI 53217
+1 877-390-3369
info@BioMarinSecuritiesLitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.